ICP
ONC

Indus Capital Partners’s BeOne Medicines Ltd ONC Stock Holding History

Indus Capital Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-106,153
Closed -$28.8M – 40
2021
Q4 		$28.8M Buy
106,153
+90,143
+563% +$30.4M 6.81% 4
2021
Q3 		$5.81M Sell
16,010
-27,568
-63% -$9.01M 1% 27
2021
Q2 		$15M Sell
43,578
-17,262
-28% -$5.72M 2.54% 14
2021
Q1 		$21.2M Sell
60,840
-43,123
-41% -$14.3M 3.66% 9
2020
Q4 		$26.9M Buy
103,963
+9,642
+10% +$2.65M 4.16% 9
2020
Q3 		$27M Sell
94,321
-13,040
-12% -$3.06M 3.99% 9
2020
Q2 		$20.2M Buy
107,361
+7,276
+7% +$1.18M 3.31% 10
2020
Q1 		$12.3M Sell
100,085
-32,158
-24% -$5.03M 2.09% 16
2019
Q4 		$21.9M Sell
132,243
-134,267
-50% -$22.3M 4.3% 7
2019
Q3 		$32.6M Buy
+266,510
New +$35.4M 5.44% 5
2019
Q1 		– Sell
-138,199
Closed -$19.4M – 43
2018
Q4 		$19.4M Sell
138,199
-68,325
-33% -$9.06M 3.5% 9
2018
Q3 		$35.6M Sell
206,524
-79,791
-28% -$13.4M 4.53% 8
2018
Q2 		$44M Sell
286,315
-277,774
-49% -$49.5M 4.43% 7
2018
Q1 		$94.8M Buy
564,089
+183,503
+48% +$24.9M 10.75% 3
2017
Q4 		$37.2M Buy
380,586
+63,751
+20% +$5.84M 3.63% 11
2017
Q3 		$32.8M Buy
+316,835
New +$23.6M 3.32% 12
2016
Q3 		– Sell
-104,599
Closed -$3.12M – 46
2016
Q2 		$3.12M Sell
104,599
-65,401
-38% -$1.92M 0.3% 31
2016
Q1 		$4.98M Buy
+170,000
New +$4.82M 0.49% 29

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Indus Capital Partners's ONC Position: Q1 2022 in Review

Indus Capital Partners sold out of BeOne Medicines Ltd (ONC) in Q1 2022, closing a stake of 106,153 shares — an estimated $28.8M sold.

Indus Capital Partners first reported a position in ONC in Q1 2016 and held it in 18 quarters. The position peaked at $94.8M in Q1 2018. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • Indus Capital Partners reported no remaining BeOne Medicines Ltd position as of Q1 2022 after selling out during the quarter.
  • Indus Capital Partners sold 106,153 BeOne Medicines Ltd shares in Q1 2022, an estimated $28.8M.
  • Indus Capital Partners first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 18 quarters.
  • Indus Capital Partners's BeOne Medicines Ltd position peaked at $94.8M in Q1 2018.
  • 239 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on Indus Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.